Description

• Title:
  Synergy of pharmacotherapy and physical activity in the treatment of obesity and cardiovascular prevention in patients with type 2 diabetes
• Creator:
  Mędrysa, Karolina;
  Jankowska, Marlena;
  Baran, Karolina;
  Jańczyk, Natalia;
  Blecharz, Gabriela;
  Presak, Michał;
  Bartnik, Katarzyna;
  Pokrzepa, Jakub Jan;
  Szwech, Julia;
  Pograniczny , Mikołaj
• Description:
  Aim of the study  The aim of this paper is to explore the synergistic role of pharmacotherapy and physical activity in the treatment of obesity and the prevention of cardiovascular diseases in patients with type 2 diabetes.  Materials and methods  This review is based on selected publications from 1999 to 2025, retrieved from PubMed, WHO, and StatPearls using keywords related to type 2 diabetes, pharmacotherapy, and physical activity. Included were guidelines, clinical trials, and meta-analyses focusing on adults with T2DM. In total, 38 sources were analyzed, covering treatments such as metformin, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and lifestyle interventions [1–28].  Results The combination of pharmacotherapy and physical activity in T2DM patients led to better glycemic control, greater weight reduction, and improved cardiovascular outcomes compared to either intervention alone.  Conclusion The management of type 2 diabetes (T2DM) and its associated complications, particularly cardiovascular disease (CVD) and obesity, requires a multifaceted approach. Pharmacotherapy and physical activity are two critical components in the treatment and prevention of these conditions. While each of these interventions offers distinct benefits, their combination provides enhanced outcomes that are greater than the sum of their individual effects.
• Object availability:
  free access
• Rights:
  Prawa autorskie (c) 2025 Karolina Mędrysa, Marlena Jankowska, Karolina Baran, Natalia Jańczyk, Gabriela Blecharz, Michał Presak, Katarzyna Bartnik, Jakub Jan Pokrzepa, Julia Szwech, Mikołaj Pograniczny;
  https://creativecommons.org/licenses/by-nc-sa/4.0
• Date:
  2025.06.11
• Type:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Language:
  English
• Source:
  Quality in Sport; Tom 42 (2025); 60480;
  Quality in Sport; Vol. 42 (2025); 60480;
  2450-3118
• Format:
  application/pdf
• Publisher:
  University Center for Sports Research, Nicolaus Copernicus University, Torun, Poland
• Relation: https://apcz.umk.pl/QS/article/view/60480/42785
• Subject:
  pharmacotherapy;
  metformin;
  GLP-1 agonist;
  SGLT-2 inhibitors;
  physical activity;
  obesity;
  cardiovascular prevention;
  , type 2 diabetes
• Identifier: https://apcz.umk.pl/QS/article/view/60480
• Data provider:
  Akademicka Platforma Czasopism
• Can I use it?:
  seek permission
• Type:
  text